Skip to main content
Recall Canary
Nicotine Transdermal System Patch 14 mg
← Back to all recalls
DRUG RECALLLOW

Nicotine Transdermal System Patch 14 mg

Aveva is recalling 14 mg Nicotine Transdermal System Patches due to elevated levels of oxidative-related impurities.

What to do

Stop using the affected patches and contact your healthcare provider or pharmacist for guidance on an alternative smoking cessation product.

Recalled
Listed
Updated
Recall No.
D-0550-2026
Agency
FDA
Firm
AVEVA Drug Delivery Systems, Inc.
Recall ID
98972
Status
ONGOING

Recall at a glance

Quantity recalled
59,808 pouches (4,272 Individual Folding Carton (IFC))

Why it was recalled

Aveva is recalling Nicotine Transdermal System Patches due to elevated levels of oxidative-related impurities found during stability testing. These impurities exceed shelf-life specifications for the affected product.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Nicotine Transdermal System Patch

Lot code
56841, 2028
Strength
14 mg
NDC / UPC
NDC 0536-5895-88

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-05-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification